Laser confocal imaging useful for AMD

Article

Scanning laser ophthalmoscopy with a lateral confocal aperture could highlight subclinical drusen and aid in the progression of monitoring in AMD patients, claims the latest paper in the British Journal of Ophthalmology.

Scanning laser ophthalmoscopy with a lateral confocal aperture could highlight subclinical drusen and aid in the progression of monitoring in AMD patients, claims the latest paper in the British Journal of Ophthalmology.

The investigation, headed by Dr Bruno Diniz, Department of Ophthalmology, Doheny Eye Institute, Los Angeles, California, USA, involved 11 eyes with non-neovascular AMD who underwent infrared imaging with a Nidek F-10 confocal SLO using multiple confocal apertures. These included the central, ring, aperture on the right side (AR), left side (AL) and with and without use of differential contrast (DC).

Colour fundus photographs were also obtained and exported into a certified grading tool. The number of drusen and the total drusen area was calculated for each image type. Paired t tests were compared between the aperture/DC modes and the colour image.

Drusen number values and area measurements attained by the AR mode were higher than the colour fundus photographs. Drusen area measurements were also higher in AL modes, compared to fundus photographs.

Addition of the DC did not appear to improve drusen detection compared to the unmodified infrared images. Therefore, the use of a lateral confocal aperture could assist in monitoring disease progression and response to emerging non-neovascular AMD therapies.

The abstract can be viewed here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.